Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
他汀类药物介导的 RAS 异戊烯化抑制可激活 ER 应激，从而增强 KRAS 突变癌症的免疫原性
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.3
doi:10.1136/jitc-2021-002474
Gi-Hoon Nam #, Minsu Kwon #, Hanul Jung, Eunbyeol Ko, Seong A Kim, Yoonjeong Choi, Su Jeong Song, Seohyun Kim, Yeji Lee, Gi Beom Kim, Jihoon Han, Jiwan Woo, Yakdol Cho, Cherlhyun Jeong, Seung-Yoon Park, Thomas M Roberts, Yong Beom Cho, In-San Kim
